Navigation Links
OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
Date:12/5/2011

to develop a specific microRNA-based profile to predict drug response in advanced ovarian cancer.   Following the development of the ovarian cancer assay, OvaGene will focus on creating additional assays for drug response in a variety of gynecologic cancers and pursue strategic partnerships to develop similar profiles in other tumor types.  Developmental studies, CLIA lab validation, and subsequent commercialization are expected to occur over the next eighteen to twenty-four months.

"We are looking forward to developing and commercializing the very first cancer microRNA diagnostic assay related to drug response," said William Ricketts, PhD, OvaGene Chief Scientific Officer. "We are at the forefront of molecular diagnostic development for gynecologic cancers and we are excited about the innovative and clinically useful microRNA drug response panels we will be bringing to market"

Neil Finkler, MD, OvaGene Chief Medical Officer, commented "The microRNA panel will provide gynecologic oncologists with a useful tool to help decide between a variety of chemotherapeutic options based on epigenetic information obtained from the patient's tumor.  With an excellent partner in the Moffitt Cancer Center, we can rapidly validate the assays and begin helping patients quickly. "

About Moffitt Cancer Center

Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt's excellence in research and contributions to clinical trials, prevention and cancer control.  Moffitt currently has 14 affiliates in Florida, one in Georgia, one in Pennsylvania and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer.  Moffitt marks a very important anniversary this year 
'/>"/>

SOURCE OvaGene Oncology Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OvaGene Oncology Licenses Gene-Based Technologies to Develop Novel Endometrial and Cervical Cancer Assays
2. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
3. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
4. US Oncology Pharmaceutical Distribution Service Wins National Safety Council Award
5. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
6. OncologySTAT Advisors Name Years Top Developments in Cancer Treatment and Research
7. First Coast Oncology to Offer Next Generation Proton Therapy
8. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
9. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
10. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
11. Varian Medical Systems Introducing OncoView(TM) - an Oncology Specific Image Management and Storage Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... ... together supply chain risk management and resiliency practitioners with luminaries and thought leaders ... practices, and be recognized for their innovations and performance excellence. At that time ...
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/v7fdpx/argentina ) has ... Market - Growth, Trends & Forecasts (2014-2020)" report ... Sensors market is estimated at $0.17 billion by 2018 ... The near future will bring Biomedical sensors ... individual. These sensors can be set to trigger alerts ...
(Date:8/31/2015)... people with Down syndrome, news from Elixirgen, LLC ... in the Science + Technology Park at Johns Hopkins, ... for people with Down syndrome and other chromosome disorders in ... Edwards syndrome aneuploidies in human cell cultures, " published ... to develop this technology into a treatment for the ...
(Date:8/31/2015)... and SHANGHAI , Aug. 31, ... company developing next-generation antibiotics, today announced positive top-line ... for its lead drug candidate MRX-I. MRX-I is ... bacteria such as MRSA and VRE, while offering ... therapeutic option than currently available oxazolidinone agents. ...
Breaking Biology Technology:Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 3Argentina Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts 2014-2020 2New Down syndrome therapy discovered 2MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2
... chemistry-driven contract research organization, announced today that its ChemRar ... the leading CRO companies conducting high quality Phase I ... continue to operate separately under the business name ... acquisition ChemDiv had worked with Prudentas, who established itself ...
... Required to Meet Growing Demand , ... Arlington, Va. ... enough grain to meet the growing demand for food, biofuels and ... around the globe take a more holistic approach to the solution, ...
... StandardsWASHINGTON, April 16 URAC , ... today that Director of Pharmacy Programs Janice Anderson, RPh, ... 21st Annual Academy of Managed Care Pharmacy (AMCP) Meeting ... care professionals dedicated solely to the issues of managed ...
Cached Biology Technology:ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center 2ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center 3DuPont Leader: Agriculture is Up to Global Productivity Challenge 2DuPont Leader: Agriculture is Up to Global Productivity Challenge 3DuPont Leader: Agriculture is Up to Global Productivity Challenge 4URAC Director of Pharmacy Programs to Speak at Academy of Managed Care Pharmacy Annual Meeting 2URAC Director of Pharmacy Programs to Speak at Academy of Managed Care Pharmacy Annual Meeting 3
(Date:8/6/2015)... , Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon ... data. Crossmatch is a world leader in multi-factor ... expertise are helping federal agencies and commercial organizations ...   "The vast majority of network ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
(Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... The amount of time families spend eating meals ... of children and teens, with families who eat together ... unhealthy weight in their children. Now, a new study ... the quality of family interactions during mealtime affected the ...
... up poor increases a person,s likelihood of health problems ... a Cornell University environmental psychologist shows that being raised ... of poverty. The study, "Loosening the Link Between ... Protective Effects of Social Capital" published in the January ...
... Tenn. Feb. 3, 2011 -- Researchers at the Department ... biohybrid photoconversion system -- based on the interaction of ... convert visible light into hydrogen fuel. Photosynthesis, ... some bacterial species, converts sunlight energy into chemical energy ...
Cached Biology News:Family mealtimes play a role in health of children with asthma 2Cornell researchers find a strong community protects adolescents from risky health behavior 2'Tall order' sunlight-to-hydrogen system works, neutron analysis confirms 2'Tall order' sunlight-to-hydrogen system works, neutron analysis confirms 3
... is a direct antibiotic-based selection system for ... colony survival, eliminating the need for costly ... provides close to 100% accuracy in recombinant ... for robot colony picking. This cloning kit ...
...
Mouse polyclonal antibody raised against a partial recombinant KCTD13. NCBI Entrez Gene ID = 253980...
Mouse monoclonal antibody raised against a partial recombinant SCARB2. NCBI Entrez Gene ID = SCARB2...
Biology Products: